April 2010
Volume 51, Issue 13
ARVO Annual Meeting Abstract  |   April 2010
Presenting Ophthalmic Signs and Symptoms of Neuroblastoma
Author Affiliations & Notes
  • E. M. Bratton
    College of Medicine,
    Univ of Tennessee Health Sci Ctr, Memphis, Tennessee
  • M. E. Hoehn
    Univ of Tennessee Health Sci Ctr, Memphis, Tennessee
  • E. B. Morris
    Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee
  • N. C. Kerr
    Univ of Tennessee Health Sci Ctr, Memphis, Tennessee
  • Footnotes
    Commercial Relationships  E.M. Bratton, None; M.E. Hoehn, None; E.B. Morris, None; N.C. Kerr, None.
  • Footnotes
    Support  Research to Prevent Blindness (RPB), Cancer Center Support (CORE), NIH Grant P30 CA 21765, American Lebanese Syrian Associated Charities (ALSAC)
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 959. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. M. Bratton, M. E. Hoehn, E. B. Morris, N. C. Kerr; Presenting Ophthalmic Signs and Symptoms of Neuroblastoma. Invest. Ophthalmol. Vis. Sci. 2010;51(13):959.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To determine the incidence of Horner's syndrome, proptosis, ecchymosis, and Opsoclonus-myoclonus-ataxia (OMA) syndrome at presentation of neuroblastoma, noting concurrent systemic findings.

Methods: : We performed a retrospective chart review at St. Jude Children’s Research Hospital, identifying 336 patients diagnosed with neuroblastoma since 1995.

Results: : Of the children diagnosed with neuroblastoma, 45 children (13.4%) had ophthalmic findings at presentation. Seven children had Horner's syndrome [57% (n=4) had associated systemic signs]. Sixteen children had ecchymosis, most with systemic signs (n=15, 93.8%). Ecchymosis was usually bilateral (n=14, 87.5%) and sometimes associated with proptosis (n=5, 31.3%). Nineteen had proptosis, 89.5% of which also had systemic signs (n=17). Three children with proptosis also had ptosis of the involved eye. Two children with proptosis had papilledema. Seven had OMA (3 with associated systemic signs, 42.9%). In addition, one child had papilledema as the only sign at presentation. The majority of ophthalmic signs occurred with other systemic signs of neuroblastoma (86.7%).

Conclusions: : Prior studies have not investigated the co-existence of ophthalmic and systemic signs in children presenting with neuroblastoma. Ophthalmic signs were noted at presentation in a minority of children with neuroblastoma. Of these, the vast majority (86.7%) had systemic findings.Ophthalmologists should be aware that most children who present with ophthalmic signs of neuroblastoma also have systemic findings. Therefore careful history and complete physical examination is warranted when ophthalmic signs are noted.

Keywords: tumors • neuro-ophthalmology: diagnosis • oncology 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.